| Literature DB >> 19262106 |
Abstract
The G45 domain of laminin-332 is cleaved in normal tissues but remains in squamous cell carcinomas. Targeting this domain using a G45 antibody reduced in vivo tumor growth and invasion and suggests a role for G45 as a new therapeutic target.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19262106 PMCID: PMC2634984 DOI: 10.4161/cam.2.2.6483
Source DB: PubMed Journal: Cell Adh Migr ISSN: 1933-6918 Impact factor: 3.405